Skip to main content

Grafa News and Videos — Page 462

Grafa Headlines

Grafa

CervoMed completes Phase 2a trial enrollment for rare frontotemporal dementia candidate

CervoMed (NASDAQ:CRVO), a clinical-stage biotechnology company focused on treating age-related brain disorders, announced today that it has finalized patient enrollment for its Phase 2a clinical trial evaluating its lead drug candidate, neflamapimod, in individuals with nonfluent variant primary progressive aphasia (nfvPPA).

Read more: CervoMed completes Phase 2a trial enrollment for rare frontotemporal dementia candidate
Grafa
Technology

Roadzen expands global footprint with $15M European insurance acquisition

Roadzen (NASDAQ:RDZN), a global leader in artificial intelligence solutions for the mobility and insurance sectors, announced today that it has signed a definitive agreement to acquire a technology-driven European Managing General Agent (MGA) specializing in short-term car rental protection.

Read more: Roadzen expands global footprint with $15M European insurance acquisition

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift